Syndax Pharmaceuticals (SNDX) Earnings Analysis
Syndax Pharmaceuticals (SNDX) next reports earnings on 2026-08-03, consensus EPS -0.45 USD. Last quarter (2026-04-30) it beat with EPS -0.48 USD vs -0.59 USD est (+18.6%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -7.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SNDX next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | -0.45 USD |
| Revenue estimate | 0.08B |
SNDX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-30 | -0.48 USD | -0.59 USD | +18.6% | Beat |
| 2026-02-26 | -0.78 USD | -0.58404 USD | -33.6% | Miss |
| 2025-11-03 | -0.7 USD | -0.74 USD | +5.4% | Beat |
| 2025-08-04 | -0.83 USD | -1 USD | +17% | Beat |
| 2025-05-05 | -0.98 USD | -1.04 USD | +5.8% | Beat |
| 2025-03-03 | -1.1 USD | -1.08 USD | -1.9% | Miss |
| 2024-08-01 | -0.8 USD | -0.91 USD | +12.1% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
SNDX valuation and analyst view
| Trailing P/E | -7.88 |
|---|---|
| Trailing EPS | -2.8082 USD |
| Price / book | 45.89 |
| Dividend yield | 0.00% |
| Market cap | 1.95B |
| Analyst consensus | Buy (20 buy / 2 hold / 0 sell) |
| Avg price target | 38.5 USD |
Related research pages
Frequently asked questions
When is Syndax Pharmaceuticals (SNDX)'s next earnings date?
Syndax Pharmaceuticals is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.45 USD and revenue estimate of 0.08B.
Did SNDX beat earnings last quarter?
In its 2026-04-30 report, SNDX posted EPS of -0.48 USD versus a -0.59 USD estimate — a beat of 18.6%.
What is SNDX's earnings track record?
Over the last 7 reported quarters with consensus data, SNDX beat estimates 5 times (71%).
What is SNDX's current P/E ratio and EPS?
SNDX trades at a trailing P/E of -7.88 on trailing EPS of -2.8081988383348553 USD.
What do analysts rate SNDX?
Analyst consensus is "Buy" across 22 ratings (0 strong buy, 20 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 38.5 USD.